Elite Pharmaceuticals Inc (ELTP)
0.1335
0.00 (0.00%)
USD |
OTCM |
Apr 18, 15:52
Elite Pharmaceuticals Revenue (TTM): 47.32M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.32M |
| September 30, 2023 | 41.03M |
| June 30, 2023 | 35.46M |
| March 31, 2023 | 34.15M |
| December 31, 2022 | 33.18M |
| September 30, 2022 | 32.91M |
| June 30, 2022 | 32.88M |
| March 31, 2022 | 32.26M |
| December 31, 2021 | 28.99M |
| September 30, 2021 | 26.06M |
| June 30, 2021 | 24.90M |
| March 31, 2021 | 25.38M |
| December 31, 2020 | 25.93M |
| September 30, 2020 | 24.94M |
| June 30, 2020 | 22.17M |
| March 31, 2020 | 17.99M |
| December 31, 2019 | 14.39M |
| September 30, 2019 | 12.03M |
| June 30, 2019 | 8.760M |
| March 31, 2019 | 7.568M |
| December 31, 2018 | 7.822M |
| September 30, 2018 | 7.663M |
| June 30, 2018 | 7.924M |
| March 31, 2018 | 7.459M |
| December 31, 2017 | 7.212M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.007M |
| June 30, 2017 | 8.069M |
| March 31, 2017 | 9.638M |
| December 31, 2016 | 13.48M |
| September 30, 2016 | 13.35M |
| June 30, 2016 | 13.61M |
| March 31, 2016 | 12.50M |
| December 31, 2015 | 8.538M |
| September 30, 2015 | 7.707M |
| June 30, 2015 | 6.017M |
| March 31, 2015 | 5.015M |
| December 31, 2014 | 4.808M |
| September 30, 2014 | 5.139M |
| June 30, 2014 | 5.041M |
| March 31, 2014 | 4.601M |
| December 31, 2013 | 5.097M |
| September 30, 2013 | 4.071M |
| June 30, 2013 | 3.547M |
| March 31, 2013 | 3.404M |
| December 31, 2012 | 2.531M |
| September 30, 2012 | 2.373M |
| June 30, 2012 | 2.013M |
| March 31, 2012 | 2.424M |
| December 31, 2011 | 2.987M |
| September 30, 2011 | 3.704M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.760M
Minimum
Jun 2019
47.32M
Maximum
Dec 2023
27.41M
Average
26.06M
Median
Sep 2021
Revenue (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |